EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies

Basmah N Aldosari, Mohamed Abbas Ibrahim, Yara Alqahtani, Amal El Sayeh F Abou El Ela

Saudi Pharmaceutical Journal · 2024-07 · 32 (7) · 102104

DOI: 10.1016/j.jsps.2024.102104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2024-07. Verfasst von Basmah N Aldosari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim in this study was to develop and evaluate a nanofluconazole (FLZ) formulation with increased solubility and permeation rate using nanosuspensions. The FLZ nanosuspensions were stabilized using a variety of stabilizing agents and surfactants in various concentrations. The FLZ nanosuspension was characterized in vitro using particle size, zeta potential, X-ray powder diffraction (XRPD), and solubility. In addition, the ex vivo ocular permeation of FLZ through a goat cornea was analyzed. The results showed that the particle size of all nanosuspension formulations was in the nanometer range from 174.5 ± 1.9 to 720.2 ± 4.77 nm; that of the untreated drug was 18.34 μm. The zeta potential values were acceptable, which indicated suitable stability for formulations. The solubility of the nanosuspensions was up to 5.7-fold higher compared with that of the untreated drug. The results of the ex vivo ocular diffusion of the FLZ nanosuspensions showed the percentage of FLZ penetrating via the goat cornea increased after using Kollicoat to stabilize the nanosuspension formulation. Consequently, when using a nanosuspension formulation of Kollicoat, the antifungal activity of the drug strengthens.

Schlagwörter

Stichwörter der Autor:innen

Corneal permeationFluconazoleNanosuspensionsSolvent evaporationStabilizers

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.

Förderung

  • King Saud University

Zitieren

APA

Aldosari, B. N., Ibrahim, M. A., Alqahtani, Y., & Abou El Ela, A. E. S. F. (2024). Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies. Saudi Pharmaceutical Journal, 32(7), 102104. https://doi.org/10.1016/j.jsps.2024.102104

Vancouver

Aldosari BN, Ibrahim MA, Alqahtani Y, Abou El Ela AESF. Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies. Saudi Pharmaceutical Journal. 2024;32(7):102104. doi:10.1016/j.jsps.2024.102104

BibTeX
@article{Aldosari2024,
  author = {Aldosari, Basmah N and Ibrahim, Mohamed Abbas and Alqahtani, Yara and Abou El Ela, Amal El Sayeh F},
  title = {Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies},
  journal = {Saudi Pharmaceutical Journal},
  year = {2024},
  volume = {32},
  number = {7},
  pages = {102104},
  doi = {10.1016/j.jsps.2024.102104}
}
Kostenlos starten →